These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24130351)

  • 21. Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes.
    Wright RJ; Newby DE; Stirling D; Ludlam CA; Macdonald IA; Frier BM
    Diabetes Care; 2010 Jul; 33(7):1591-7. PubMed ID: 20587725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Vitamins C and E on Endothelial Function in Type 1 Diabetes Mellitus.
    Cazeau RM; Huang H; Bauer JA; Hoffman RP
    J Diabetes Res; 2016; 2016():3271293. PubMed ID: 26783536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.
    Toft-Nielsen MB; Madsbad S; Holst JJ
    Diabetes Care; 1999 Jul; 22(7):1137-43. PubMed ID: 10388979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study.
    Pitocco D; Zaccardi F; Tarzia P; Milo M; Scavone G; Rizzo P; Pagliaccia F; Nerla R; Di Franco A; Manto A; Rocca B; Lanza GA; Crea F; Ghirlanda G
    Diabetes Obes Metab; 2013 May; 15(5):427-31. PubMed ID: 23167274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucagon-like peptide 1 attenuates the acceleration of gastric emptying induced by hypoglycemia in healthy subjects.
    Plummer MP; Jones KL; Annink CE; Cousins CE; Meier JJ; Chapman MJ; Horowitz M; Deane AM
    Diabetes Care; 2014 Jun; 37(6):1509-15. PubMed ID: 24598243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure.
    Halbirk M; Nørrelund H; Møller N; Holst JJ; Schmitz O; Nielsen R; Nielsen-Kudsk JE; Nielsen SS; Nielsen TT; Eiskjaer H; Bøtker HE; Wiggers H
    Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H1096-102. PubMed ID: 20081109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged deterioration of endothelial dysfunction in response to postprandial lipaemia is attenuated by vitamin C in Type 2 diabetes.
    Anderson RA; Evans LM; Ellis GR; Khan N; Morris K; Jackson SK; Rees A; Lewis MJ; Frenneaux MP
    Diabet Med; 2006 Mar; 23(3):258-64. PubMed ID: 16492208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of a continuous GLP-1 infusion compared with a structured insulin infusion protocol to reach normoglycemia in nonfasted type 2 diabetic patients: a clinical pilot trial.
    Sourij H; Schmölzer I; Kettler-Schmut E; Eder M; Pressl H; Decampo A; Wascher TC
    Diabetes Care; 2009 Sep; 32(9):1669-71. PubMed ID: 19528368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incorporating incretin-based therapies into clinical practice: differences between glucagon-like Peptide 1 receptor agonists and dipeptidyl peptidase 4 inhibitors.
    Davidson JA
    Mayo Clin Proc; 2010 Dec; 85(12 Suppl):S27-37. PubMed ID: 21106865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
    Nauck MA; Sauerwald A; Ritzel R; Holst JJ; Schmiegel W
    Diabetes Care; 1998 Nov; 21(11):1925-31. PubMed ID: 9802745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes.
    Zhang Z; Chen X; Lu P; Zhang J; Xu Y; He W; Li M; Zhang S; Jia J; Shao S; Xie J; Yang Y; Yu X
    Cardiovasc Diabetol; 2017 Mar; 16(1):31. PubMed ID: 28249585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exenatide exerts direct protective effects on endothelial cells through the AMPK/Akt/eNOS pathway in a GLP-1 receptor-dependent manner.
    Wei R; Ma S; Wang C; Ke J; Yang J; Li W; Liu Y; Hou W; Feng X; Wang G; Hong T
    Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E947-57. PubMed ID: 27072494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose metabolism in critically ill patients: are incretins an important player?
    Nielsen ST; Krogh-Madsen R; Møller K
    J Intensive Care Med; 2015 May; 30(4):201-8. PubMed ID: 24065782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GLP-1 receptor agonists for type 2 diabetes mellitus: recent developments and emerging agents.
    Trujillo JM; Nuffer W
    Pharmacotherapy; 2014 Nov; 34(11):1174-86. PubMed ID: 25382096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance.
    Chen H; Karne RJ; Hall G; Campia U; Panza JA; Cannon RO; Wang Y; Katz A; Levine M; Quon MJ
    Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H137-45. PubMed ID: 16126809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High doses of vitamin C reverse Escherichia coli endotoxin-induced hyporeactivity to acetylcholine in the human forearm.
    Pleiner J; Mittermayer F; Schaller G; MacAllister RJ; Wolzt M
    Circulation; 2002 Sep; 106(12):1460-4. PubMed ID: 12234948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus.
    Ting HH; Timimi FK; Boles KS; Creager SJ; Ganz P; Creager MA
    J Clin Invest; 1996 Jan; 97(1):22-8. PubMed ID: 8550838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin infusion suppresses while glucose infusion induces Toll-like receptors and high-mobility group-B1 protein expression in mononuclear cells of type 1 diabetes patients.
    Dandona P; Ghanim H; Green K; Sia CL; Abuaysheh S; Kuhadiya N; Batra M; Dhindsa S; Chaudhuri A
    Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E810-8. PubMed ID: 23403945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride.
    Basu A; Charkoudian N; Schrage W; Rizza RA; Basu R; Joyner MJ
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1289-95. PubMed ID: 17711996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.